investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

How do genome alterations cause human lung cancer?

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Eric Haura

Specialized Program of Research Excellence (SPORE) in Lung Cancer

Trachea, bronchus and lung

Pathology

Michael J Eck

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Trachea, bronchus and lung

Jeffrey Schlom

Human Immune Responses to Tumor Antigens for Cancer Vaccine Development

Trachea, bronchus and lung

Pathology

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

Trachea, bronchus and lung

Amato J Giaccia

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

Trachea, bronchus and lung

Radiation Oncology

James K Chen

Chemical genetic dissection of Hipk4-dependent Hedgehog pathway activation

Trachea, bronchus and lung

David FitzGerald

Bio-Therapies for the Treatment of Cancer

Trachea, bronchus and lung

Allan Weissman

Determining the Fate of Transmembrane Proteins

Trachea, bronchus and lung

Sherry L Emery

Tobacco Control in a Rapidly Changing Media Environment

Trachea, bronchus and lung